{"result": "(\"entity\"<|>LABORATORIOS MEAD-JHONSON<|>ORGANIZATION<|>Laboratorios Mead-Jhonson is a company that produces dietary supplements for metabolic disorders, including PFD® for phenylketonuria treatment.)\n##\n(\"entity\"<|>LABORATORIOS SHS<|>ORGANIZATION<|>Laboratorios SHS manufactures dietary products such as Maxivit® and Energyvit® for individuals with metabolic conditions.)\n##\n(\"entity\"<|>LABORATORIOS CASEN RECORDATI<|>ORGANIZATION<|>Laboratorios Casen Recordati produces Kcalip®, a dietary supplement for managing phenylketonuria.)\n##\n(\"entity\"<|>VITAFLO<|>ORGANIZATION<|>Vitaflo is a company that provides specialized dietary products, including Prozero®, for metabolic disorders.)\n##\n(\"entity\"<|>PHENYLKETONURIA<|>EVENT<|>Phenylketonuria is a metabolic disorder that requires dietary management to prevent severe health issues.)\n##\n(\"entity\"<|>HYPERPHENYLALANINEMIA<|>EVENT<|>Hyperphenylalaninemia is a biochemical phenotype characterized by elevated phenylalanine levels, which can lead to various clinical forms including classic phenylketonuria.)\n##\n(\"relationship\"<|>LABORATORIOS MEAD-JHONSON<|>PHENYLKETONURIA<|>Laboratorios Mead-Jhonson produces dietary supplements specifically designed to manage phenylketonuria.<|>8)\n##\n(\"relationship\"<|>LABORATORIOS SHS<|>PHENYLKETONURIA<|>Laboratorios SHS manufactures products that help in the dietary management of phenylketonuria.<|>8)\n##\n(\"relationship\"<|>LABORATORIOS CASEN RECORDATI<|>PHENYLKETONURIA<|>Laboratorios Casen Recordati provides dietary supplements that are essential for the treatment of phenylketonuria.<|>8)\n##\n(\"relationship\"<|>VITAFLO<|>PHENYLKETONURIA<|>Vitaflo offers specialized dietary products that are crucial for managing phenylketonuria.<|>8)\n##\n(\"relationship\"<|>HYPERPHENYLALANINEMIA<|>PHENYLKETONURIA<|>Hyperphenylalaninemia is a broader term that includes phenylketonuria as one of its clinical forms.<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: •  El tratamiento dietético de los errores congénitos\n      na se denominan aa semiesenciales porque solo                         del metabolismo de las proteínas tendrá como\n      pueden ser sintetizados a partir de aa precurso-                      objetivo:\n      res esenciales (fenilalanina y metionina, respectiva-                 1.  Limitar la ingesta de aquel o aquellos aa cuya\n      mente). En determinadas situaciones estos aa semi-                        vía metabólica esté afectada, hasta un requeri-\n\n\n\n                                                                 305\n---\n 306      BLOQUE: PROTEÍNAS Y AMINOÁCIDOS\n\n\n\n          miento mínimo que asegure un adecuado cre-                     El diagnóstico bioquímico se establece mediante la\n          cimiento y desarrollo.                                      determinación de niveles plasmáticos de Phe mediante\n      2.  Suplementar la dieta con aquel o aquellos aa                espectrometría de masas en tándem (MS/MS) superio-\n          que no se sintetizan.                                       res a 120-150 μmol/l y se confirma mediante el estudio\n      3.  Aumentar la ingesta calórica para conseguir un              mutacional.\n          ahorro proteico máximo y evitar que las proteí-\n          nas se empleen como fuente energética. Por                  2.2.   Clasificación y fenotipo clínico\n          ello, es muy importante evitar los ayunos pro-                 Debido al gran número de mutaciones, el espectro\n          longados. Estas necesidades energéticas se cu-              clínico es muy amplio y, en la actualidad, la clasifica-\n          brirán con alimentos naturales con bajo o nulo              ción más aceptada es la que tiene en cuenta las con-\n          contenido proteico, alimentos manufacturados                centraciones plasmáticas de Phe y la tolerancia de Phe.\n          de bajo contenido proteico (pasta, pan, galletas               En este sentido, podemos clasificar las hiperfenilala-\n          especiales) y con suplementos energéticos a                 ninemias/PKU:\n          base de polímeros de glucosa y/ó grasas (PFD®\n          de Laboratorios Mead-Jhonson; Maxivit® y Ener-                 a. Fenilcetonuria clásica: las concentraciones plas-\n          gyvit® de Laboratorios SHS, Kcalip® de Laborato-                  máticas de Phe al diagnóstico son superiores a\n          rios Casen Recordati , Prozero® de Vitaflo).                      1 200    μmol/l; la tolerancia de Phe es inferior a\n      4.  Aumentar en lo posible la proporción de pro-                      350 mg/día. Suelen ser formas muy severas que\n          teínas naturales de alto valor biológico (PNA-                    cursan con retraso mental y motor graves si no\n          VB): legumbres, leche y derivados, carne y pes-                   están tratadas.\n          cado, huevo.                                                   Fenilcetonuria       moderada:         las    concentraciones\n      5.  Vigilar los posibles efectos secundarios de una                   plasmáticas de Phe al diagnóstico suelen ser 600-\n          ingesta proteica limitada (vitaminas, minerales,                  1200     μmol/l; la tolerancia de Phe es inferior a\n          oligoelementos).       Puede     ser  necesario     suple-        350-400 mg/día.\n          mentarlos.                                                     Fenilcetonuria     leve:   las  concentraciones        plasmáti-\n      6.  En ocasiones es necesario complementar el                         cas de Phe al diagnóstico suelen ser 360- 600\n          aporte     proteico     con    preparados      especiales         μmol/l; la tolerancia de Phe suele ser de 400-600\n          para cada enfermedad, que contienen todos                         mg/día.\n          los aa excepto el o los que están afectados. Es-               Hiperfenilalaninemia        benigna     (HPA):     las   concen-\n          tos preparados no deben ser utilizados como                       traciones plasmáticas de Phe al diagnóstico sue-\n          única fuente proteica en situaciones de des-                      len ser 120-360 μmol/l. Es una forma benigna,\n          compensación, ya que se convierten en una                         leve y no requiere tratamiento dietético.\n          fuente nitrogenada tóxica.                                     b. Hiperfenilalaninemia maligna: son las que afectan\n                                                                            al   sistema    de   la  coenzima      tetrahidrobipterina\n2.   Fenilcetonuria                                                         (BH4) y su enzima, la DHPR. Estos pacientes mani-\n                                                                            fiestan síntomas de afectación neurológica debi-\n2.1.    Consideraciones generales                                           do al déficit de neurotransmisores y no suelen\n   La hiperfenilalaninemia es un término genérico que                       responder al tratamiento dietético.\nse otorga a un fenotipo bioquímico en el que existe un                2.\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}